Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | CDKAL1 |
| Upstream (Parents) |
|---|
| (<<) ZNF45 → CDKAL1 |
| (<<) SRSF5 → CDKAL1 |
| (<<) SOCS6 → CDKAL1 |
| (<<) ZFY///ZFX → CDKAL1 |
| Downstream (Children) |
|---|
| CDKAL1 → MEPE (>>) |
| CDKAL1 → PRKACA (>>) |
| CDKAL1 → HTN3 (>>) |
| CDKAL1 → CATR1 (>>) |
| CDKAL1 → RAP2B (>>) |
| CDKAL1 → PAK7 (>>) |
| CDKAL1 → C11orf67 (>>) |
| CDKAL1 → TP53 (>>) |
| CDKAL1 → PCSK1N (>>) |
| CDKAL1 → RPL10P15///RPL10P8///RPL10P6///RPL10P16///RPL10 (>>) |
| CDKAL1 → ZNF550 (>>) |
| CDKAL1 → PGK2 (>>) |
| CDKAL1 → FKRP (>>) |
| CDKAL1 → NOS1AP (>>) |
| CDKAL1 → IRS4 (>>) |
| CDKAL1 → ALPK1 (>>) |
| CDKAL1 → RFX3 (>>) |
| CDKAL1 → CTRC (>>) |
| CDKAL1 → MED16 (>>) |
